Profile data is unavailable for this security.
About the company
Nanobiotix SA is a France-based nanomedicine company. The Company designs and manufactures nanoparticles that safely enhance the efficacy of radiation therapy in the treatment of cancer. It develops new tools for cancer that utilize a physical mode of action at the cellular level of the cancer cell. The Company's NanoXray technology comprises three products. Local treatment (surgery and radiotherapy) provides potential cure and gives the systemic treatment a better chance to life expectancy. NanoXray products are developed for the efficacy of radiotherapy in the tumor cell. Nanobiotix is a spin-off of the State University of New York (SUNY) at Buffalo.
- Revenue in USD (TTM)32.06m
- Net income in USD-42.34m
- Incorporated2003
- Employees102.00
- LocationNanobiotix SA60 rue de WattigniesPARIS 75012FranceFRA
- Phone+33 140260470
- Fax+33 140260444
- Websitehttps://www.nanobiotix.com
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Metagenomi Inc | 44.76m | -68.26m | 263.06m | 236.00 | -- | -- | -- | 5.88 | -1.82 | -1.82 | 1.19 | 5.73 | -- | -- | -- | 189,644.10 | -- | -- | -- | -- | -- | -- | -152.50 | -- | -- | -- | 0.00 | -- | 160.21 | -- | -56.57 | -- | -- | -- |
| Ventyx Biosciences Inc | 0.00 | -192.96m | 263.39m | 79.00 | -- | 0.9083 | -- | -- | -3.29 | -3.29 | 0.00 | 4.12 | 0.00 | -- | -- | 0.00 | -59.46 | -- | -63.22 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -77.97 | -- | -- | -- |
| Akebia Therapeutics Inc | 194.62m | -51.93m | 263.81m | 167.00 | -- | -- | -- | 1.36 | -0.2778 | -0.2778 | 1.04 | -0.1572 | 0.6512 | 2.22 | 4.89 | 1,165,407.00 | -17.37 | -37.42 | -28.19 | -56.00 | 78.76 | 69.13 | -26.68 | -82.25 | 1.03 | -7.64 | 8.46 | -- | -33.46 | -1.30 | 44.89 | -- | -- | -- |
| Invivyd Inc | 0.00 | -198.64m | 264.67m | 94.00 | -- | 1.38 | -- | -- | -1.81 | -1.81 | 0.00 | 1.61 | 0.00 | -- | -- | 0.00 | -64.88 | -- | -73.98 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 17.68 | -- | -- | -- |
| Chromadex Corp | 83.57m | -4.94m | 266.59m | 106.00 | -- | 9.33 | -- | 3.19 | -0.0659 | -0.0659 | 1.11 | 0.3795 | 1.53 | 2.25 | 21.38 | 788,396.30 | -9.06 | -42.11 | -14.00 | -65.14 | 60.76 | 59.68 | -5.91 | -30.64 | 1.70 | -- | 0.0008 | -- | 15.99 | 21.50 | 70.15 | -- | -36.66 | -- |
| Monte Rosa Therapeutics Inc | 0.00 | -135.35m | 266.82m | 133.00 | -- | 1.49 | -- | -- | -2.64 | -2.64 | 0.00 | 3.57 | 0.00 | -- | -- | 0.00 | -41.90 | -- | -47.16 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -24.75 | -- | -- | -- |
| Rapt Therapeutics Inc | 0.00 | -116.80m | 267.96m | 131.00 | -- | 1.80 | -- | -- | -3.05 | -3.05 | 0.00 | 4.27 | 0.00 | -- | -- | 0.00 | -53.15 | -46.30 | -57.90 | -49.97 | -- | -- | -- | -3,522.72 | -- | -- | 0.00 | -- | -100.00 | -- | -39.31 | -- | -20.31 | -- |
| Nektar Therapeutics | 90.12m | -276.06m | 268.08m | 137.00 | -- | 2.13 | -- | 2.97 | -1.46 | -1.46 | 0.4743 | 0.6844 | 0.1626 | 1.91 | 25.08 | 657,824.80 | -49.80 | -31.02 | -55.82 | -34.63 | 62.53 | 78.04 | -306.31 | -372.21 | 6.14 | -21.17 | 0.00 | -- | -2.10 | -40.35 | 25.03 | -- | -42.89 | -- |
| Werewolf Therapeutics Inc | 19.94m | -37.37m | 270.49m | 47.00 | -- | 2.19 | -- | 13.56 | -1.05 | -1.05 | 0.5595 | 2.85 | 0.119 | -- | 4.82 | 424,319.20 | -22.30 | -- | -25.62 | -- | -- | -- | -187.37 | -- | -- | -- | 0.2609 | -- | 21.60 | -- | 30.56 | -- | -- | -- |
| Zura Bio Ltd | 0.00 | -69.24m | 271.93m | 14.00 | -- | 3.14 | -- | -- | -4.38 | -4.38 | 0.00 | 1.36 | 0.00 | -- | -- | 0.00 | -49.98 | -- | -60.56 | -- | -- | -- | -- | -- | -- | -- | 0.0123 | -- | -- | -- | -2,050.99 | -- | -- | -- |
| Inozyme Pharma Inc | 0.00 | -71.17m | 272.41m | 59.00 | -- | 1.94 | -- | -- | -1.39 | -1.39 | 0.00 | 2.27 | 0.00 | -- | -- | 0.00 | -41.86 | -45.00 | -45.82 | -48.90 | -- | -- | -- | -- | -- | -- | 0.2417 | -- | -- | -- | -6.13 | -- | 2.85 | -- |
| Nanobiotix SA - ADR | 32.06m | -42.34m | 273.71m | 102.00 | -- | -- | -- | 8.54 | -1.17 | -1.17 | 0.8681 | -0.0417 | 0.3912 | -- | 19.59 | 314,281.80 | -51.67 | -- | -120.56 | -- | -- | -- | -132.08 | -- | -- | -1.98 | 1.04 | -- | -- | -- | 30.40 | -- | -- | -- |
| Sanara Medtech Inc | 64.99m | -4.30m | 274.55m | 107.00 | -- | 6.06 | -- | 4.22 | -0.5219 | -0.5219 | 7.85 | 5.25 | 0.9635 | 1.90 | 8.37 | 607,381.70 | -6.58 | -17.73 | -8.17 | -22.07 | 87.92 | 88.08 | -6.83 | -17.13 | 1.04 | -18.75 | 0.1786 | -- | 41.77 | 61.93 | 45.79 | -- | 99.09 | -- |
| Vanda Pharmaceuticals Inc. | 192.64m | 2.51m | 277.02m | 203.00 | 108.55 | 0.5026 | 50.19 | 1.44 | 0.0439 | 0.0439 | 3.35 | 9.47 | 0.3004 | 11.60 | 5.69 | 948,965.50 | 0.3912 | 6.61 | 0.4547 | 7.62 | 92.32 | 90.55 | 1.30 | 15.18 | 4.92 | -- | 0.00 | 0.00 | -24.27 | -0.0496 | -60.02 | -36.96 | -56.77 | -- |
| Sutro Biopharma Inc | 153.73m | -106.79m | 277.59m | 302.00 | -- | 1.38 | -- | 1.81 | -1.79 | -1.79 | 2.56 | 2.45 | 0.3503 | -- | 7.12 | 509,043.00 | -24.34 | -25.48 | -29.77 | -29.75 | -- | -- | -69.47 | -113.71 | -- | -- | 0.0264 | -- | 126.84 | 31.96 | 10.41 | -- | 22.61 | -- |
| Acrivon Therapeutics Inc | 0.00 | -60.39m | 280.63m | 58.00 | -- | 1.69 | -- | -- | -2.73 | -2.73 | 0.00 | 5.38 | 0.00 | -- | -- | 0.00 | -37.80 | -- | -40.30 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -93.76 | -- | -- | -- |
Data as of May 01 2024. Currency figures normalised to Nanobiotix SA's reporting currency: US Dollar USD
7.74%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Baillie Gifford & Co.as of 31 Dec 2023 | 2.87m | 6.09% |
| Perceptive Advisors LLCas of 31 Dec 2023 | 555.07k | 1.18% |
| BlackRock Fund Advisorsas of 31 Dec 2023 | 218.52k | 0.46% |
| UBS Financial Services, Inc.as of 31 Dec 2023 | 3.10k | 0.01% |
| GAMMA Investing LLCas of 31 Mar 2024 | 1.15k | 0.00% |
| Citigroup Global Markets, Inc. (Investment Management)as of 31 Dec 2023 | 635.00 | 0.00% |
| Qube Research & Technologies Ltd.as of 31 Dec 2023 | 343.00 | 0.00% |
| Morgan Stanley & Co. International Plcas of 31 Dec 2023 | 300.00 | 0.00% |
| RBC Capital Markets LLC (Investment Management)as of 31 Dec 2023 | 250.00 | 0.00% |
| Bank of America, NA (Private Banking)as of 31 Dec 2023 | 141.00 | 0.00% |
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
